{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:39:50Z","timestamp":1791257990692,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T00:00:00Z","timestamp":1391990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T00:00:00Z","timestamp":1391990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1038\/leu.2014.65","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T07:42:04Z","timestamp":1392018124000},"page":"1698-1704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Detection of MYD88 L265P in peripheral blood of patients with Waldenstr\u00f6m\u2019s Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance"],"prefix":"10.1038","volume":"28","author":[{"given":"L","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z R","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Tripsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Lindeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S P","family":"Treon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,10]]},"reference":[{"key":"BFleu201465_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/sonc.2003.50082","volume":"30","author":"RG Owen","year":"2003","unstructured":"Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 2003; 30: 110\u2013115.","journal-title":"Semin Oncol"},{"key":"BFleu201465_CR2","volume-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"S Swerdlow","year":"2008","unstructured":"Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th edn. IARC Press: Lyon, France, 2008."},{"key":"BFleu201465_CR3","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2009-05-174359","volume":"114","author":"SP Treon","year":"2009","unstructured":"Treon SP . How I treat Waldenstr\u00f6m macroglobulinemia. Blood 2009 17 114: 2375\u20132385.","journal-title":"Blood"},{"key":"BFleu201465_CR4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood.V61.5.911.911","volume":"61","author":"BR Smith","year":"1983","unstructured":"Smith BR, Robert NJ, Ault KA . In Waldenstrom's macroglobulinemia the quantity of detectable circulating monoclonal B lymphocytes correlates with clinical course. Blood 1983; 61: 911\u2013914.","journal-title":"Blood"},{"key":"BFleu201465_CR5","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1182\/blood-2003-11-4024","volume":"104","author":"J Kriangkum","year":"2004","unstructured":"Kriangkum J, Taylor BJ, Treon SP, Mant MJ, Belch AR, Pilarski LM . Clonotypic IgM V\/D\/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood. Blood 2004; 104: 2134\u20132142.","journal-title":"Blood"},{"key":"BFleu201465_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature09671","volume":"3470","author":"VN Ngo","year":"2011","unstructured":"Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 2011; 3470: 115\u2013119.","journal-title":"Nature"},{"key":"BFleu201465_CR7","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y et al. MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N Engl J Med 2012; 367: 826\u2013833.","journal-title":"N Engl J Med"},{"key":"BFleu201465_CR8","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP, Hunter ZR . MYD88 L265P Somatic Mutation in IgM MGUS. N Engl J Med 2012; 367: 2256\u20132257.","journal-title":"N Engl J Med"},{"key":"BFleu201465_CR9","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","volume":"121","author":"L Xu","year":"2013","unstructured":"Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X et al. MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood 2013; 121: 2051\u20132058.","journal-title":"Blood"},{"key":"BFleu201465_CR10","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMc1211959","volume":"367","author":"O Landgren","year":"2012","unstructured":"Landgren O, Staudt L . MYD88 L265P somatic mutation in IgM MGUS. N Engl J Med 2012; 367: 2255\u20132256.","journal-title":"N Engl J Med"},{"key":"BFleu201465_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/leu.2012.257","volume":"27","author":"N Gachard","year":"2013","unstructured":"Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D et al. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia\/lymphoplasmacytic lymphomas. Leukemia 2013; 27: 183\u2013189.","journal-title":"Leukemia"},{"key":"BFleu201465_CR12","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","volume":"121","author":"M Varettoni","year":"2013","unstructured":"Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Pascutto C et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Blood 2013; 121: 2522\u20132528.","journal-title":"Blood"},{"key":"BFleu201465_CR13","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/leu.2013.62","volume":"27","author":"C Jimenez","year":"2013","unstructured":"Jimenez C, Sebastian E, Del Carmen Chillon M, Giraldo P, Mariano Hern\u00e1ndez J, Escalante F et al. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia. Leukemia 2013; 27: 1722\u20131728.","journal-title":"Leukemia"},{"key":"BFleu201465_CR14","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1182\/blood-2012-06-436329","volume":"121","author":"S Poulain","year":"2013","unstructured":"Poulain S, Roumier C, Decambron A, Renneville A, Herbaux C, Bertrand E et al. MYD88 L265P mutation in Waldenstrom\u2019s macroglobulinemia. Blood 2013; 121: 4504\u20134511.","journal-title":"Blood"},{"key":"BFleu201465_CR15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/bjh.12313","volume":"161","author":"W Willenbacher","year":"2013","unstructured":"Willenbacher W, Willenbacher E, Brunner A, Manzi C . Improved accuracy of discrimination between IgM multiple myeloma and Waldenstrom macroglobulinaemia by testing for MYD88 L265P mutations. Br J Haematol 2013; 161: 902\u2013904.","journal-title":"Br J Haematol"},{"key":"BFleu201465_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1309\/AJCP10ZCLFZGYZIP","volume":"140","author":"SL Ondrejka","year":"2013","unstructured":"Ondrejka SL, Lin JJ, Warden DW, Durkin L, Cook JR, Hsi ED . MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders. Am J Clin Pathol 2013; 140: 387\u2013394.","journal-title":"Am J Clin Pathol"},{"key":"BFleu201465_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/leu.2013.294","volume":"28","author":"N Argentou","year":"2014","unstructured":"Argentou N, Vassilopoulos G, Ioannou M, Germenis AE, Speletas M . Rapid detection of MYD88-L265P mutation by PCR-RFLP in B-cell lymphoproliferative disorders. Leukemia 2014; 28: 447\u2013449.","journal-title":"Leukemia"},{"key":"BFleu201465_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"475","author":"XS Puente","year":"2011","unstructured":"Puente XS, Pinyol M, Quesada V, Conde L, Ord\u00f3\u00f1ez GR, Villamor N et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101\u2013105.","journal-title":"Nature"},{"key":"BFleu201465_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/sj.icb.7100095","volume":"85","author":"T Watters","year":"2007","unstructured":"Watters T, Kenny EF, O\u2019Neill LAJ . Structure, function and regulation of the Toll\/IL-1 receptor adaptor proteins. Immunol Cell Biol 2007; 85: 411\u2013419.","journal-title":"Immunol Cell Biol"},{"key":"BFleu201465_CR20","doi-asserted-by":"publisher","first-page":"28093","DOI":"10.1074\/jbc.M109.004465","volume":"284","author":"M Loiarro","year":"2009","unstructured":"Loiarro M, Gallo G, Fant\u00f2 N, De Santis R, Carminati P, Ruggiero V et al. Identification of critical residues of the MYD88 death domain involved in the recruitment of downstream kinases. J Biol Chem 2009; 284: 28093\u2013281023.","journal-title":"J Biol Chem"},{"key":"BFleu201465_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature09121","volume":"465","author":"SC Lin","year":"2010","unstructured":"Lin SC, Lo YC, Wu H . Helical assembly in the MYD88-IRAK4-IRAK2 complex in TLR\/IL-1R signaling. Nature 2010; 465: 885\u2013891.","journal-title":"Nature"},{"key":"BFleu201465_CR22","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1182\/blood-2012-12-475111","volume":"122","author":"G Yang","year":"2013","unstructured":"Yang G, Zhou Y, Liu X, Xu L, Cao Y, Manning RJ et al. A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenstrom macroglobulinemia. Blood 2013; 122: 1222\u20131232.","journal-title":"Blood"},{"key":"BFleu201465_CR23","doi-asserted-by":"crossref","unstructured":"Treon SP, Tripsas C, Yang G, Cao Y, Xu L, Hunter ZR et al2013 A Prospective Multicenter Study of the Bruton\u2019s Tyrosine Kinase Inhibitor Ibrutinib In Patients With Relapsed or Refractory Waldenstrom\u2019s Macroglobulinemia. Blood 2013; 122, Abstract 251.","DOI":"10.1182\/blood.V122.21.251.251"},{"key":"BFleu201465_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1053\/sonc.2003.50038","volume":"30","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Treon SP, Alexanian R, Barlogie B, Bj\u00f6rkholm M, Dhodapkar M et al. Prognostic markers and criteria to initiate therapy in Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the second international workshop on Waldenstrom\u2019s macroglobulinemia. Semin Oncol 2003; 30: 116\u2013120.","journal-title":"Semin Oncol"},{"key":"BFleu201465_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3109\/10428199909058476","volume":"34","author":"TL Kiss","year":"1999","unstructured":"Kiss TL, Xu WM, Jamal N, Messner HA . Comparative testing of peripheral blood and bone marrow for BCR-ABL transcripts in patients post allogeneic bone marrow transplantation and during interferon treatment for chronic myeloid leukemia. Leuk Lymphoma 1999; 34: 493\u2013500.","journal-title":"Leuk Lymphoma"},{"key":"BFleu201465_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2012-02-366054","volume":"120","author":"F Passamonti","year":"2012","unstructured":"Passamonti F . How I treat polycythemia vera. Blood 2012; 120: 275\u2013284.","journal-title":"Blood"},{"key":"BFleu201465_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1182\/blood-2011-08-371179","volume":"119","author":"E Tiacci","year":"2012","unstructured":"Tiacci E, Schiavoni G, Forconi F, Santi A, Trentin L, Ambrosetti A et al. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood 2012; 119: 192\u2013195.","journal-title":"Blood"},{"key":"BFleu201465_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1182\/blood-2007-12-129395","volume":"112","author":"HT Ngo","year":"2008","unstructured":"Ngo HT, Leleu X, Lee J, Jia X, Melhem M, Runnels J et al. SDF-1\/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia. Blood 2008; 112: 150\u2013158.","journal-title":"Blood"},{"key":"BFleu201465_CR29","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1182\/blood-2012-03-419440","volume":"120","author":"LS Hodge","year":"2012","unstructured":"Hodge LS, Ziesmer SC, Yang ZZ, Secreto FJ, Gertz MA, Novak AJ et al. IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia. Blood 2012; 120: 3774\u20133782.","journal-title":"Blood"},{"key":"BFleu201465_CR30","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1158\/1078-0432.CCR-06-2511","volume":"13","author":"SP Treon","year":"2007","unstructured":"Treon SP, Hunter ZR, Matous J, Joyce RM, Mannion B, Advani R et al. Multicenter clinical trial of bortezomib in relapsed\/refractory Waldenstrom\u2019s macroglobulinemia: results of WMCTG Trial 03-248. Clin Cancer Res 2007; 13: 3320\u20133325.","journal-title":"Clin Cancer Res"},{"key":"BFleu201465_CR31","doi-asserted-by":"crossref","unstructured":"Treon SP, Tripsas CK, Meid K, Patterson CJ, Heffner LT, Eradat H et al. Prospective, multicenter study of the MTOR inhibitor everolimus (RAD001) as primary therapy in Waldenstrom\u2019s macroglobulinemia. Blood 2013; 122, Abstract 1822.","DOI":"10.1182\/blood.V122.21.1822.1822"},{"key":"BFleu201465_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.6004\/jnccn.2013.0004","volume":"11","author":"KC Anderson","year":"2013","unstructured":"Anderson KC, Alsina M, Bensinger W, Biermann JS, Cohen AD, Devine S et al. Multiple Myeloma, version 1.2013. J Natl Compr Canc Netw 2013; 11: 11\u201317.","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201465.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201465","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201465.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:20:22Z","timestamp":1648743622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,10]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["BFleu201465"],"URL":"https:\/\/doi.org\/10.1038\/leu.2014.65","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,10]]},"assertion":[{"value":"2 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}